Get startedLog in
    Picture of ORYZON Genomics SA logo

    ORY — ORYZON Genomics SA News Story

    0.000.00%
    es flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Oryzon Announces Publication Of Final Phase IIa Results With Vafidemstat In Psychiatry

    Picture of ORYZON Genomics SA logoORYZON Genomics SA
    14/02/2025 07:10
    Feb 14 (Reuters) - Oryzon Genomics SA  ORY.MC :
    * ANNOUNCES JOURNAL PUBLICATION OF FINAL PHASE IIA REIMAGINE
RESULTS WITH VAFIDEMSTAT IN PSYCHIATRY AND CLINICAL
NEUROSCIENCES
    * VAFIDEMSTAT DEMONSTRATED A RELEVANT CLINICAL BENEFIT IN
REDUCING
AGITATION/AGGRESSION ACROSS ALL STUDIED PATIENT POPULATIONS

Source text: https://tinyurl.com/mrcts4h8
Further company coverage:  ORY.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on ORYZON Genomics SA

    See all news